Kowa Company Ltd v. Sawai USA Inc.
1:14-cv-00978
Overview
Parties
Defendant
Plaintiff
Nissan Chemical Industries Ltd. Operating Company
Represented By
2 Attorneys ListedBarnard, Mezzanotte, Pinnie, Seelaus & Kraft, LLP
1205 N. Orange Street, Wilmington, DE 19801
DLA Piper LLP
1201 N. Market Street, Suite 2100, Wilmington, DE 19801
Kowa Pharmaceuticals America Inc. Operating Company
Represented By
2 Attorneys ListedBarnard, Mezzanotte, Pinnie, Seelaus & Kraft, LLP
1205 N. Orange Street, Wilmington, DE 19801
DLA Piper LLP
1201 N. Market Street, Suite 2100, Wilmington, DE 19801
Kowa Company Ltd Operating Company
Represented By
2 Attorneys ListedBarnard, Mezzanotte, Pinnie, Seelaus & Kraft, LLP
1205 N. Orange Street, Wilmington, DE 19801
DLA Piper LLP
1201 N. Market Street, Suite 2100, Wilmington, DE 19801
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
Sawai USA, Inc. et al. v. Nissan Chemical Industries Ltd. et al.
Sawai USA, Inc. et al. v. Nissan Chemical Industries Ltd. et al.
Mylan Pharmaceuticals Inc. v. Nissan Chemical Industries, Ltd. et al.
Kowa Company, Ltd. v. Hetero Drugs Limited
Kowa Company Ltd. v. Apotex Inc.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5856336
Quinoline type mevalonolactones
|
Filed: 1992-05-15
Issued: 1999-01-05
|
Expired (Term Ended)
+3153d PTA
Expires: 2021-01-01
|
|
|
US6465477
Stable pharmaceutical composition
|
Filed: 1999-11-08
Issued: 2002-10-15
|
Expired (Term Ended)
Expires: 2019-11-08
|
|
|
US8557993
Crystalline forms of pitavastatin calcium
|
Filed: 2012-10-31
Issued: 2013-10-15
|
Active (5.9 yrs remaining)
Expires: 2032-10-31
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
High PTA (+3153 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).